Fusion Pharmaceuticals

$8.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.27 (-3.10%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FUSN and other stocks, options, and ETFs commission-free!

About FUSN

Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease.

CEO
John Valliant
Employees
51
Headquarters
Hamilton, Ontario
Founded
2014
Market Cap
368.99M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
39.71K
High Today
$9.22
Low Today
$8.29
Open Price
$8.80
Volume
22.58K
52 Week High
$19.00
52 Week Low
$8.29

FUSN Earnings

-$2.99
-$1.99
-$1.00
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, Pre-Market

You May Also Like

USD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure